|Bid||49.60 x 800|
|Ask||51.02 x 1000|
|Day's range||49.50 - 50.76|
|52-week range||49.35 - 127.20|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||9.06|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Emergent (EBS) is set to provide manufacturing services for doses of Providence Therapeutics' COVID-19 vaccine candidate as well as for its bulk drug substance.
ATTO, BLDP, NTB, CCJ and EBS have been added to the Zacks Rank #5 (Strong Sell) List on August 2, 2021.